COVID-19: Advertising Responsibly
The ASA continues its drive to ensure responsible advertising during the COVID-19 pandemic.
At the outset of the pandemic the ASA took swift action to highlight to advertisers it would act quickly and robustly against ads that exploited people’s health related anxieties and the difficult financial or employment circumstances many people were facing. The ASA also published guidance on the main areas in which it believed ads may be deemed problematic. Despite this there have been a number of ads which have fallen foul of the CAP Code.
The latest series of problematic ads related to a vitamin C drink containing claims such as “Vitamin-C has been proven to boost immunity” which, taken in the midst of the pandemic, could be taken to imply that the drink could help to prevent, treat or cure COVID-19. Making such claims is not permitted unless the products in question are authorised on the EU Register of nutrition and health claims, which this product was not. It is also prohibited to make claims that food and supplements can prevent, treat or cure human disease. The ASA therefore held that the ads must not appear again.
Below we have outlined the ASA guidance and rulings since the beginning of the pandemic to highlight the main areas of concern which may have the potential to grossly undermine the UK’s response to the pandemic.
Key Areas of concern and ASA Rulings
1. Medicines and medical devices:
The key issue in this space is that ‘medical or medicinal claims’ can only be made for products where they are licenced medicines or appropriately marked medical devices.
- The ASA banned an ad which promoted an “Anti-Corona Virus Face Mask”.
- The ASA banned a series of ads which promoted a “New Nano Tech Face Mask” and implied that the mask would offer protection against being infected by COVID-19.
2. Alternative and complementary therapies
The ASA made clear that it was likely to consider COVID-19 a condition for which medical supervision should be sought.
- The ASA banned advertising claims on websites and in social media made by three clinics offering IV drip treatments which made medicinal claims that implied they could prevent or treat COVID-19.
3. Food or food supplements
As seen above, the ASA made clear that ads that make health related claims and/or suggest a product may help protect consumers from infection of COIVD-19 by, for example, supporting their immune system, were likely to be viewed as problematic.
4. Fear, distress and social responsibility
The ASA highlighted that ads should not exploit an audience’s fear in order to mislead them into buying a product.
- The ASA banned an ad which stated “British Build, beds proudly made in the UK. No Nasty imports”. The ad also contained imagery whereby a cartoon mattress was wearing a green surgical mask. In the ASA’s view the ad was likely to cause serious or widespread offence as in combination with the image the reference to “nasty imports” was likely to be read as a negative reference to immigration or race.
Ads in any of the special interest areas above will likely receive additional scrutiny from both the public and regulators. Advertisers must exercise special caution and be mindful of how ads may be perceived by the public in the current heightened state of awareness, especially if those ads contain health-related claims.
For more information on any of the ASA Rulings set out above, please use the following link.
IBA Annual Conference
The IBA heads to Miami for its 2022 Annual Conference bringing together thousands hundreds of lawyers from around the world.
Joint Venture Opportunities
Join our panel where we will discuss various topics including Joint Venture structuring and Partner procurement.
Mind your business: Safeguarding your business against loss of mental capacity
Practical considerations to safeguard your business against loss of mental capacity.
FT Wealth quotes Sarah Anticoni on forum shopping
"Being the first to file for divorce is not a foolproof way of securing an English hearing"
What can UK investors interested in Life Sciences learn from their more experienced, including US, counterparts?
The recent tie-up between Canary Wharf and Kadans demonstrates the enthusiasm to access the lucrative UK life sciences market.
Helen Coward writes for Tax Journal on the main purpose test for SDLT group relief
Mainly ignored? The main purpose test for SDLT group relief
The Ayes have it - Collateral Warranties can be a ‘Construction Contract’
The Court of Appeal handed down its judgment in the case of Abbey Healthcare (Mill Hill) Limited v Simply Construct (UK) LLP
Charles Russell Speechlys advises Caretech Holdings PLC on its proposed £870.3 million take private
Charles Russell Speechlys is advising the independent board of Caretech Holdings PLC, in its take private sale to Amalfi Bidco Limited.
Charles Russell Speechlys advising Battery Ventures on the sale of SPT Labtech for £650 million.
Battery Ventures has raised over $9 billion to invest in software and services, enterprise infrastructure, and much more around the world.
Windrush Day 2022 – supporting access to justice
Charles Russell Speechlys is proud to continue supporting survivors of the Windrush scandal in their fight for justice.
The Leasehold Reform (Ground Rent) Act 2022: Landlords and developers beware serious sanctions for non-compliance
The Leasehold Reform (Ground Rent) Act 2022 received Royal Assent on 8 February 2022 and will come into force on 30 June 2022.
EG quotes Emma Preece on the Picturehouse and BNY Mellon rent arrears cases
“The case is being closely watched by landlords and tenants alike as the impact of the pandemic lives on in the commercial property sector”
Charles Russell Speechlys has advised long-standing client Stonegate on a series A investment into Peckwater Brands
Stonegate is one of the largest pub companies in the UK with a rich portfolio that covers over 4,500 sites.
Pro bono support for major office premises move for charity in Stoke-on-Trent
Emmaus entities provide safe homes, community support and meaningful work to formerly homeless people across the UK.
Financier Worldwide quotes Rachel Warren on the UK’s Economic Crime Act
Evaluating the UK’s Economic Crime Act
Julia Cox and Felicity Chapman write for International Adviser on the rise of pre-nups in the UK
Julia Cox and Felicity Chapman write for International Adviser on the rise of pre-nups
Property Patter: Reasonable Endeavours
What does it mean to use ‘best’, ‘all’ or ‘reasonable’ endeavours?
Could the UK’s Life Sciences Vision be restricted by its Immigration Policy?
We explore some of the visa options that may be open to businesses in the sector and their relative pros and cons.
New Swiss succession law on the transfer of businesses
On 10 June 2022, the Federal Council adopted its Message amending the Civil Code on the transfer of businesses by succession.
Joshua Green writes for Spear's Magazine on Wagatha Christie’s lessons for HNWs
Wagatha Christie’s lessons for HNWs